|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 3.630 USD | -2.16% |
|
-2.68% | +3.42% |
| 08-11 | Rocket Pharmaceuticals' Danon, PKP2-ACM Updates Seen as Key H2 Catalysts, Wedbush Says | MT |
| 08-11 | Wedbush Adjusts PT on Rocket Pharmaceuticals to $15 From $16, Keeps Outperform Rating | MT |
| Market Cap | 398M 342M 323M 294M 550M 37.91B 552M 3.82B 1.48B 19.32B 1.5B 1.46B 61.1B | P/E 2026 * |
-13.1x | P/E 2027 * | -2.6x |
|---|---|---|---|---|---|
| Enterprise Value | 77.88M 66.93M 63.05M 57.47M 107M 7.41B 108M 747M 288M 3.78B 292M 286M 11.94B | EV / Sales 2026 * |
70.3x | EV / Sales 2027 * | 5.63x |
| Free-Float |
96.76% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RCKT | Delayed | |
CBOE
| RCKT | Real-time | |
|
Tradegate
| 9IP1 | Real-time | |
|
Deutsche Boerse AG
| 9IP1 | Delayed | |
|
Börse Stuttgart
| 9IP1 | Delayed | |
|
Boerse Muenchen
| 9IP1 | Real-time |
Last Transcript : Rocket Pharmaceuticals, Inc.
| 1 day | -2.16% | ||
| 1 week | -2.68% | ||
| Current month | -2.42% | ||
| 1 month | +0.55% | ||
| 3 months | +34.44% | ||
| 6 months | -17.69% | ||
| Current year | +3.42% |
| 1 week | 3.62 |  | 3.92 |
| 1 month | 3.27 | | 3.99 |
| Current year | 2.53 | | 5.45 |
| 1 year | 2.53 | | 5.45 |
| 3 years | 2.19 | | 32.52 |
| 5 years | 2.19 | | 36.87 |
| 10 years | 2.19 | | 67.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 51 | 2018-01-03 |
Martin Wilson
DFI | Director of Finance/CFO | 49 | 2025-09-07 |
Syed Rizvi
CTO | Chief Tech/Sci/R&D Officer | 59 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gaurav D. Shah
BRD | Director/Board Member | 51 | 2018-01-03 |
Rod Wong
CHM | Chairman | 49 | 2017-12-31 |
David Southwell
BRD | Director/Board Member | 65 | 2017-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/18/26 | Sell | Chief Executive Officer | -2,293 | 0.0021% | ||
| 8/18/26 | Sell | Chief Financial Officer | -631 | 0.0006% | ||
| 8/13/26 | Sell | Chief Executive Officer | -2,837 | 0.0026% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -2.68% | +11.35% | -76.79% | 407M | |
| -0.94% | +0.31% | +40.04% | +103.25% | 69.19B | |
| -0.07% | -2.37% | +33.44% | +78.50% | 62.97B | |
| +3.13% | +6.00% | -12.19% | +390.48% | 27.27B | |
| -0.54% | -3.74% | -4.41% | -18.31% | 24.78B | |
| -0.93% | -1.29% | +25.30% | +16.70% | 25.8B | |
| -1.43% | -0.61% | +22.71% | -19.01% | 20.11B | |
| -4.27% | +2.67% | +219.02% | +362.48% | 18.47B | |
| -1.43% | -1.80% | -8.64% | +537.09% | 14.88B | |
| +1.14% | +2.53% | +54.76% | +163.82% | 14.29B | |
| Average | -0.64% | -0.33% | +38.14% | +153.82% | 27.82B | |
| Weighted average by Cap. | -0.39% | -0.76% | +36.84% | +141.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.11M 951K 896K 817K 1.53M 105M 1.53M 10.61M 4.1M 53.68M 4.16M 4.07M 170M | 11.25M 9.66M 9.1M 8.3M 15.52M 1.07B 15.58M 108M 41.65M 545M 42.21M 41.3M 1.72B |
| Net income | -17.76M -15.26M -14.38M -13.11M -24.51M -1.69B -24.6M -170M -65.79M -861M -66.66M -65.22M -2.72B | -182M -157M -148M -135M -252M -17.36B -253M -1.75B -676M -8.85B -685M -670M -27.98B |
| Net Debt | -321M -276M -260M -237M -442M -30.5B -444M -3.07B -1.19B -15.54B -1.2B -1.18B -49.16B | -335M -288M -271M -247M -463M -31.89B -464M -3.21B -1.24B -16.25B -1.26B -1.23B -51.4B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | US$3.630 | -2.16% | 871,418 |
| 26-09-08 | US$3.710 | -3.89% | 754,693 |
| 26-09-04 | US$3.860 | +1.85% | 888,541 |
| 26-09-03 | US$3.790 | -1.81% | 1,071,388 |
| 26-09-02 | US$3.860 | +3.49% | 1,164,989 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCKT Stock
Select your edition
All financial news and data tailored to specific country editions
